Switch to:
More From Other Websites
Blog Coverage Celgene's Multiple Sclerosis Drug Reported Positive Phase-III Results Feb 21 2017
Celgene MS Drug Reports Positive Phase 3 Data Feb 20 2017
Forget Alexion, Buy these 4 Biotech Stocks Instead Feb 20 2017
7:30 am Celgene announces its phase III SUNBEAM trial, evaluating the efficacy and safety of... Feb 20 2017
Celgene MS Drug Wins In Trial; Will Safety Top Novartis, Biogen? Feb 17 2017
Stocks Quietly Mixed In Afternoon; Skyworks Breaks Out, Celgene Bases Feb 17 2017
Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial Feb 17 2017
CELGENE CORP /DE/ Files SEC form 8-K, Other Events Feb 17 2017
Celgene Announces Positive Results from Phase III SUNBEAM Trial of Oral Ozanimod in Patients with... Feb 17 2017
Agios (AGIO) Q4 Loss Narrower than Expected; Revenues Up Y/Y Feb 16 2017
Cramer fires back at naysayers: Here's your proof that th... Feb 15 2017
Proof the rally is real Feb 15 2017
CELGENE CORP /DE/ Financials Feb 15 2017
Celgene Could Have One More Powerful Move Higher Feb 15 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK